The S&P 500 edged 0.2% higher on Tuesday, March 25, despite a report showing that consumer confidence fell to its lowest ...

Ever wondered why Chinese Democracy took so long to make? This is the truly unbelievable story of a year in the life of Axl ...

Both supporters and critics praise Columbia University’s interim president for her openness. But will she stand up to Donald ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular ...

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

The pharmaceutical ingredients manufacturer will conduct three rounds of job cuts starting in May and continuing through 2026 ...

Merck Foundation together with Africa First Ladies and Ministries of Health has been building cancer care capacity and ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...